Five Steps for Integrating BCMA Bispecific Innovations: Clinical Data to Clinical Practice in RRMM
33:20
Five Steps for Integrating BCMA Bispecific Innovations: Clinical Data to Clinical Practice in RRMM
12 сағат бұрын
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC
48:02
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC
Күн бұрын
Pharmacy Takes on Navigating the Therapeutic Landscape for Endometrial & Cervical Cancers
1:04:14
Pharmacy Takes on Navigating the Therapeutic Landscape for Endometrial & Cervical Cancers
14 күн бұрын
Modern Team-Based Therapeutic Management for Bladder Cancer Care
1:02:43
Modern Team-Based Therapeutic Management for Bladder Cancer Care
14 күн бұрын
Striking Back at ALL With Antibody Regimens
41:22
Striking Back at ALL With Antibody Regimens
14 күн бұрын
Harnessing Innovation in Bladder Cancer Care
1:23:25
Harnessing Innovation in Bladder Cancer Care
14 күн бұрын
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
28:34
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
14 күн бұрын
Ten Steps for Highly Successful Myeloma Care
1:24:16
Ten Steps for Highly Successful Myeloma Care
21 күн бұрын
How Nurses Maximize the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer
57:45
How Nurses Maximize the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer
21 күн бұрын
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices
1:16:38
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices
21 күн бұрын
Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer
59:06
Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer
Ай бұрын
Democratizing the CAR-T Experience
1:20:33
Democratizing the CAR-T Experience
Ай бұрын
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Cancer
1:01:33
Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Cancer
Ай бұрын
Screening and Early Intervention as the Keys to Success in Lung Cancer
1:03:47
Screening and Early Intervention as the Keys to Success in Lung Cancer
Ай бұрын
Prescriptions for Successful Myeloma Care
54:55
Prescriptions for Successful Myeloma Care
Ай бұрын
Navigating Multidisciplinary Assessment and Treatment Decisions in Early Breast Cancer
54:18
Navigating Multidisciplinary Assessment and Treatment Decisions in Early Breast Cancer
Ай бұрын
The Convergence of Interventional Radiologists and Oncologists in HCC
52:53
The Convergence of Interventional Radiologists and Oncologists in HCC
Ай бұрын
Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma
1:23:36
Collaborative Care and Next Steps With Adjuvant and Neoadjuvant Immunotherapy for Melanoma
2 ай бұрын
From Resistance to Resilience in R/R CLL
38:41
From Resistance to Resilience in R/R CLL
2 ай бұрын
Redefining Endometrial and Ovarian Carcinoma Care
1:17:35
Redefining Endometrial and Ovarian Carcinoma Care
2 ай бұрын
Advancing ADCs in Gynecologic Cancers
59:56
Advancing ADCs in Gynecologic Cancers
2 ай бұрын
Exploring Newer Time-Limited BTKi Combinations in CLL
53:10
Exploring Newer Time-Limited BTKi Combinations in CLL
2 ай бұрын
Cracking Down on Post-Transplant CMV
53:16
Cracking Down on Post-Transplant CMV
2 ай бұрын
Updates on CAR-T and BCMA Antibodies in Multiple Myeloma
52:28
Updates on CAR-T and BCMA Antibodies in Multiple Myeloma
2 ай бұрын
Canceling the Cascade of VOD/SOS
51:42
Canceling the Cascade of VOD/SOS
2 ай бұрын
The “Immunosurge” Continues: Expanding the Role of Immunotherapy in NSCLC
58:37
The “Immunosurge” Continues: Expanding the Role of Immunotherapy in NSCLC
2 ай бұрын
Innovative Options Alongside HCT in AML
50:46
Innovative Options Alongside HCT in AML
2 ай бұрын
Optimizing the Use of Standard Therapies and Accelerating the Transition of Emerging Options in SCLC
53:11
Optimizing the Use of Standard Therapies and Accelerating the Transition of Emerging Options in SCLC
2 ай бұрын
Peer Pressure: Do You Know Your ADCs? Targeted Delivery of Cytotoxic Payloads in Lung Cancer
54:35
Peer Pressure: Do You Know Your ADCs? Targeted Delivery of Cytotoxic Payloads in Lung Cancer
2 ай бұрын
Пікірлер